PKM and non-small cell lung carcinoma: Because patient-derived and established NSCLC cell lines showed overexpression of PKM2 and PKM2 enzyme activities, we hypothesized that inhibiting enzyme activity by small molecule inhibitor (SMI) or gene silencing by shRNA (shRNA-PKM2) might influence NSCLC growth kinetics.